Cargando…

Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review

There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Guido, Manissero, Davide, Oppia, Maria Vittoria, Tone, Keiko, Cai, Bin, Longshaw, Christopher, Venditti, Carolina, Petrosillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459762/
https://www.ncbi.nlm.nih.gov/pubmed/32913619
http://dx.doi.org/10.4081/idr.2020.8510
_version_ 1783576445396713472
author Granata, Guido
Manissero, Davide
Oppia, Maria Vittoria
Tone, Keiko
Cai, Bin
Longshaw, Christopher
Venditti, Carolina
Petrosillo, Nicola
author_facet Granata, Guido
Manissero, Davide
Oppia, Maria Vittoria
Tone, Keiko
Cai, Bin
Longshaw, Christopher
Venditti, Carolina
Petrosillo, Nicola
author_sort Granata, Guido
collection PubMed
description There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients hospitalized between November 1(st), 2015 and October 31(st), 2016. Of 29 patients, 66% had respiratory tract infections. Median duration of hospitalization was 28 days and ~50% of patients were admitted to the intensive care unit, with 77% remaining for >2 weeks. Median time to obtain respiratory culture results was 5 days. Isolation of patients with diagnosed CR-GN infection took ≥5 days in >50% of patients. A majority (76%) of patients received ≥1 antibiotic before providing a specimen for culture; a total of 17 antibiotic treatments were used. Overall, 72% of patients, and 68% of those with respiratory infections, were discharged alive; 38% were discharged without further antibiotics. The difficulties in achieving effective management in patients with CR-GN infections are largely due to complex co-morbidities, a history of prior antibiotic treatment, and multiple referrals across health care facilities.
format Online
Article
Text
id pubmed-7459762
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-74597622020-09-09 Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review Granata, Guido Manissero, Davide Oppia, Maria Vittoria Tone, Keiko Cai, Bin Longshaw, Christopher Venditti, Carolina Petrosillo, Nicola Infect Dis Rep Article There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients hospitalized between November 1(st), 2015 and October 31(st), 2016. Of 29 patients, 66% had respiratory tract infections. Median duration of hospitalization was 28 days and ~50% of patients were admitted to the intensive care unit, with 77% remaining for >2 weeks. Median time to obtain respiratory culture results was 5 days. Isolation of patients with diagnosed CR-GN infection took ≥5 days in >50% of patients. A majority (76%) of patients received ≥1 antibiotic before providing a specimen for culture; a total of 17 antibiotic treatments were used. Overall, 72% of patients, and 68% of those with respiratory infections, were discharged alive; 38% were discharged without further antibiotics. The difficulties in achieving effective management in patients with CR-GN infections are largely due to complex co-morbidities, a history of prior antibiotic treatment, and multiple referrals across health care facilities. PAGEPress Publications, Pavia, Italy 2020-08-05 /pmc/articles/PMC7459762/ /pubmed/32913619 http://dx.doi.org/10.4081/idr.2020.8510 Text en ©Copyright: the Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Granata, Guido
Manissero, Davide
Oppia, Maria Vittoria
Tone, Keiko
Cai, Bin
Longshaw, Christopher
Venditti, Carolina
Petrosillo, Nicola
Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title_full Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title_fullStr Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title_full_unstemmed Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title_short Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
title_sort insights into the clinical management of carbapenemresistant gram-negative infections: an italian retrospective clinical chart review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459762/
https://www.ncbi.nlm.nih.gov/pubmed/32913619
http://dx.doi.org/10.4081/idr.2020.8510
work_keys_str_mv AT granataguido insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT manisserodavide insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT oppiamariavittoria insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT tonekeiko insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT caibin insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT longshawchristopher insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT venditticarolina insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview
AT petrosillonicola insightsintotheclinicalmanagementofcarbapenemresistantgramnegativeinfectionsanitalianretrospectiveclinicalchartreview